27.9 C
New York
Sunday, June 14, 2026

Tag: accessibility

newssourceFORcompanyinformationcontent1marketreleases

Saputo Reports Financial Results for the First Quarter of Fiscal 2026 Ended June 30, 2025

MONTRÉAL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX: SAP) (we, Saputo or the Company) reported today its financial results for the first quarter of fiscal 2026, which ended on June 30, 2025. All amounts in this news release are in millions of Canadian dollars (CDN), except per share amounts, unless otherwise indicated, and are presented according to International Financial Reporting Standards (IFRS).

Stibo Systems Earns Microsoft Solutions Partner Designations in Key AI Sectors

AARHUS, Denmark, Aug. 7, 2025 /PRNewswire/ -- Stibo Systems, a global master data management (MDM) solutions provider, has deepened its strategic collaboration with Microsoft,...

Zapp EV Secures Uplisting to OTCQB Venture Market

Zapp's ordinary shares will trade on the OTCQB Venture Market under the existing ticker symbol ZAPPF.

Big Jump Leverages AI-Driven Content Strategy to Boost Organic Traffic and Brand Visibility for PONS.ai, F45 Kwun Tong, and Hang Po Transportation

Hong Kong, Aug. 7, 2025 /PRNewswire/ -- Hong Kong-based digital transformation consultancy Big Jump Digital announced today that its AI marketing platform has successfully delivered...

WSPN Brings Next-Generation Stablecoin Innovation to Conviction 2025 Vietnam

TORTOLA, British Virgin Islands, Aug. 7, 2025 /PRNewswire/ -- Worldwide Stablecoin Payment Network (WSPN), a leading stablecoin infrastructure provider with its flagship product stablecoin WUSD,...

Artmarket.com: Double-digit growth in Q2 2025, Revolutionary Artprice-Perplexity AI rapprochement: The Mixed Subscription for the Second Half of 2025/2026 Will Redefine the Intelligence of...

PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding President, and the employees of Artprice are mobilizing all resources toward AI,...

Artmarket.com: Double-digit growth in Q2 2025, Revolutionary Artprice-Perplexity AI rapprochement: The Mixed Subscription for the Second Half of 2025/2026 Will Redefine the Intelligence of...

PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding President, and the employees of Artprice are mobilizing all resources toward AI,...

INDOCHINO and Nordstrom deepen partnership with another five new shop-in-shops across the U.S.

VANCOUVER, BC, Aug. 6, 2025 /PRNewswire/ - INDOCHINO, the global leader in made‑to‑measure apparel, and Nordstrom, the leading fashion retailer, are excited to announce...

INDOCHINO and Nordstrom deepen partnership with another five new shop-in-shops across the U.S.

VANCOUVER, BC, Aug. 6, 2025 /CNW/ - INDOCHINO, the global leader in made‑to‑measure apparel, and Nordstrom, the leading fashion retailer, are excited to announce...

Record Quarter as Savaria Delivers $16.3M of Net Earnings and Reaches 20.6% Adjusted EBITDA Margin* in Q2 2025

LAVAL, Quebec, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Savaria Corporation (“Savaria”) (TSX: SIS), one of the global leaders in the accessibility industry, is pleased to announce its results for the second quarter of 2025.

YOUCANIC Unveils the UCAN-II-C: A Revolutionary Full System Diagnostic Scanner

Empowering Car Owners and Mechanics with Next-Generation Diagnostic Tools 
Empowering Car Owners and Mechanics with Next-Generation Diagnostic Tools

New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation

Presentations showcased at World Transplant Congress in San Francisco demonstrate HOPE reduces the cost of liver transplantation by shortening the index hospitalization and decreasing...

Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC)

CORAL GABLES, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced the National Comprehensive Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Small Cell Lung Cancer (SCLC) now include new additions involving Lambert Eaton myasthenic syndrome (LEMS), amifampridine (FIRDAPSE®), and the tests for PQ- and N-type voltage-gated calcium channel (VGCC) antibodies.

Blue Sky Expands the Principal Target at the Corcovo Uranium Project, Argentina

TSX Venture Exchange: BSKFrankfurt Stock Exchange: MAL2OTCQB Venture Market (OTC): BKUCF VANCOUVER, BC, Aug. 6, 2025 /CNW/ - Blue Sky Uranium Corp. (TSXV: BSK) (FSE: MAL2) (OTC:...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAccessibility

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers